ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,544Medicare Part D Prescriptions Filled, Including Refills

Rank: 339 out of 1125

$622K Total Retail Price of All Prescriptions

Rank: 303 out of 1125

507 Patients Receiving at Least One Drug in Part D
70% Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 507 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 389 262 106 1 4
LEVOTHYROXINE SODIUM 387 306 100 2 3
SIMVASTATIN 259 196 79 3 5
GABAPENTIN 258 167 62 4 10
CLONAZEPAM 254 215 48 B 5 32
FUROSEMIDE 212 156 80 6 7
ZOLPIDEM TARTRATE 202 117 45 7 33
AMOXICILLIN 195 122 123 8 84
TRAMADOL HCL 193 144 58 9 31
MELOXICAM 192 158 77 10 25
HYDROCODONE-ACETAMINOPHEN 183 159 44 S3 11 1
NEXIUM 180 123 42 12 20
LISINOPRIL 158 119 50 13 2
ATORVASTATIN CALCIUM 150 108 41 14 9
ATENOLOL 147 114 42 15 21
METFORMIN HCL 139 100 36 16 8
METOPROLOL TARTRATE 134 88 33 17 11
LORAZEPAM 132 96 27 B 18 30
IBUPROFEN 129 42 49 19 65
AMLODIPINE BESYLATE 128 113 43 20 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 94 38 21 28
PREDNISONE 117 79 63 22 44
ESTRADIOL 117 76 25 R 22 133
LOSARTAN-HYDROCHLOROTHIAZIDE 104 79 24 24 56
GLYBURIDE-METFORMIN HCL 103 53 20 R 25 191
PRAVASTATIN SODIUM 102 82 36 26 13
TRAMADOL HCL-ACETAMINOPHEN 97 72 28 27 206
TRIAMCINOLONE ACETONIDE 96 75 55 28 130
PROAIR HFA 94 68 35 29 39
CRESTOR 94 61 20 29 29
POTASSIUM CHLORIDE 93 73 32 31 14
AZITHROMYCIN 91 56 72 32 47
ADVAIR DISKUS 90 70 23 33 61
ALPRAZOLAM 90 48 22 B 33 16
RANITIDINE HCL 89 51 22 35 24
CITALOPRAM HBR 87 59 28 36 19
CLOPIDOGREL 86 81* 25 37 15
MONTELUKAST SODIUM 85 59 21 38 35
VALSARTAN-HYDROCHLOROTHIAZIDE 84 52 18 39 102
HYDROCHLOROTHIAZIDE 79 74* 22 40 12
METFORMIN HCL ER 70 50 26 41 59
TRAZODONE HCL 70 38 16 41 36
PANTOPRAZOLE SODIUM 69 57 24 43 27
NAPROXEN 68 28 25 44 81
LOSARTAN POTASSIUM 66 47 16 45 23
SYMBICORT 63 42 27 46 107
MECLIZINE HCL 62 57* 34 47 115
CIPROFLOXACIN HCL 60 47 45 48 68
CELEBREX 59 47 17 49 83
POLYETHYLENE GLYCOL 3350 58 42 17 50 54
DILTIAZEM 24HR ER 56 40 11 51 153
PIOGLITAZONE HCL 54 32 13 R 52 95
TOPIRAMATE 52 <11 <11 53 141
PAROXETINE HCL 51 32 16 54 49
QUETIAPINE FUMARATE 51 <11 <11 A 54 76
CEPHALEXIN 51 46* 45 54 86
TIZANIDINE HCL 50 14 18 57 74
ISOSORBIDE MONONITRATE ER 50 45* 15 57 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.